Upgrades
According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The current stock performance of Target shows a 52-week-high of $254.87 and a 52-week-low of $137.16. Moreover, at the end of the last trading period, the closing price was at $149.25.
According to Redburn Partners, the prior rating for MongoDB Inc (NASDAQ:MDB) was changed from Sell to Neutral. For the second quarter, MongoDB had an EPS of $0.23, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $519.54 and a 52-week-low of $166.61. At the end of the last trading period, MongoDB closed at $182.35.
For Diamondrock Hospitality Co (NYSE:DRH), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. In the second quarter, Diamondrock Hospitality showed an EPS of $0.36, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.14 and a 52-week-low of $7.18. Diamondrock Hospitality closed at $8.50 at the end of the last trading period.
B of A Securities upgraded the previous rating for Owens-Corning Inc (NYSE:OC) from Underperform to Buy. Owens-Corning earned $3.83 in the second quarter, compared to $2.60 in the year-ago quarter. The stock has a 52-week-high of $101.12 and a 52-week-low of $72.97. At the end of the last trading period, Owens-Corning closed at $82.43.
For Juniper Networks Inc (NYSE:JNPR), Piper Sandler upgraded the previous rating of Underweight to Neutral. In the second quarter, Juniper Networks showed an EPS of $0.42, compared to $0.43 from the year-ago quarter. The current stock performance of Juniper Networks shows a 52-week-high of $38.14 and a 52-week-low of $25.18. Moreover, at the end of the last trading period, the closing price was at $26.61.
Raymond James upgraded the previous rating for Enviva Inc (NYSE:EVA) from Outperform to Strong Buy. In the second quarter, Enviva showed an EPS of $0.26, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $91.06 and a 52-week-low of $45.88. Enviva closed at $52.31 at the end of the last trading period.
According to Goldman Sachs, the prior rating for EOG Resources Inc (NYSE:EOG) was changed from Neutral to Buy. For the second quarter, EOG Resources had an EPS of $2.74, compared to year-ago quarter EPS of $1.73. The stock has a 52-week-high of $147.99 and a 52-week-low of $88.29. At the end of the last trading period, EOG Resources closed at $120.90.
Cowen & Co. upgraded the previous rating for Xylem Inc (NYSE:XYL) from Market Perform to Outperform. In the second quarter, Xylem showed an EPS of $0.66, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $121.05 and a 52-week-low of $72.08. Xylem closed at $90.55 at the end of the last trading period.
According to Barclays, the prior rating for Jamf Holding Corp (NASDAQ:JAMF) was changed from Equal-Weight to Overweight. For the second quarter, Jamf Holding had an EPS of $0.03, compared to year-ago quarter EPS of $0.05. The current stock performance of Jamf Holding shows a 52-week-high of $39.62 and a 52-week-low of $19.20. Moreover, at the end of the last trading period, the closing price was at $21.34.
RBC Capital upgraded the previous rating for PotlatchDeltic Corp (NASDAQ:PCH) from Sector Perform to Outperform. For the second quarter, PotlatchDeltic had an EPS of $1.61, compared to year-ago quarter EPS of $2.77. The current stock performance of PotlatchDeltic shows a 52-week-high of $60.70 and a 52-week-low of $39.10. Moreover, at the end of the last trading period, the closing price was at $42.63.
See all analyst ratings upgrades.
Downgrades
According to Roth Capital, the prior rating for Acushnet Holdings Corp (NYSE:GOLF) was changed from Buy to Neutral. Acushnet Hldgs earned $0.91 in the second quarter, compared to $1.08 in the year-ago quarter. The current stock performance of Acushnet Hldgs shows a 52-week-high of $53.94 and a 52-week-low of $37.46. Moreover, at the end of the last trading period, the closing price was at $45.76.
William Blair downgraded the previous rating for Green Dot Corp (NYSE:GDOT) from Outperform to Market Perform. Green Dot earned $0.74 in the second quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.14 and a 52-week-low of $17.50. Green Dot closed at $19.29 at the end of the last trading period.
Barclays downgraded the previous rating for The Descartes Systems Group Inc (NASDAQ:DSGX) from Equal-Weight to Underweight. In the second quarter, Descartes Systems Gr showed an EPS of $0.27, compared to $0.27 from the year-ago quarter. The current stock performance of Descartes Systems Gr shows a 52-week-high of $82.86 and a 52-week-low of $56.19. Moreover, at the end of the last trading period, the closing price was at $68.36.
Deutsche Bank downgraded the previous rating for Packaging Corp of America (NYSE:PKG) from Hold to Sell. For the second quarter, Packaging Corp of America had an EPS of $3.23, compared to year-ago quarter EPS of $2.17. At the moment, the stock has a 52-week-high of $168.50 and a 52-week-low of $110.56. Packaging Corp of America closed at $115.94 at the end of the last trading period.
According to Deutsche Bank, the prior rating for International Paper Co (NYSE:IP) was changed from Hold to Sell. International Paper earned $1.24 in the second quarter, compared to $1.06 in the year-ago quarter. The current stock performance of International Paper shows a 52-week-high of $50.23 and a 52-week-low of $30.69. Moreover, at the end of the last trading period, the closing price was at $33.23.
For Masco Corp (NYSE:MAS), B of A Securities downgraded the previous rating of Neutral to Underperform. Masco earned $1.14 in the second quarter, compared to $1.14 in the year-ago quarter. The current stock performance of Masco shows a 52-week-high of $71.06 and a 52-week-low of $45.27. Moreover, at the end of the last trading period, the closing price was at $47.81.
For Hayward Holdings Inc (NYSE:HAYW), B of A Securities downgraded the previous rating of Neutral to Underperform. Hayward Holdings earned $0.29 in the second quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.38 and a 52-week-low of $8.30. Hayward Holdings closed at $9.01 at the end of the last trading period.
According to Wedbush, the prior rating for Carvana Co (NYSE:CVNA) was changed from Outperform to Neutral. For the second quarter, Carvana had an EPS of $2.35, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $240.58 and a 52-week-low of $17.05. At the end of the last trading period, Carvana closed at $18.22.
B of A Securities downgraded the previous rating for Mohawk Industries Inc (NYSE:MHK) from Neutral to Underperform. In the second quarter, Mohawk Industries showed an EPS of $4.41, compared to $4.45 from the year-ago quarter. The stock has a 52-week-high of $192.00 and a 52-week-low of $88.84. At the end of the last trading period, Mohawk Industries closed at $96.51.
According to JMP Securities, the prior rating for Palomar Holdings Inc (NASDAQ:PLMR) was changed from Market Outperform to Market Perform. In the second quarter, Palomar Hldgs showed an EPS of $0.73, compared to $0.51 from the year-ago quarter. The current stock performance of Palomar Hldgs shows a 52-week-high of $95.20 and a 52-week-low of $44.01. Moreover, at the end of the last trading period, the closing price was at $89.16.
Goldman Sachs downgraded the previous rating for PDC Energy Inc (NASDAQ:PDCE) from Buy to Neutral. In the second quarter, PDC Energy showed an EPS of $5.11, compared to $1.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $89.22 and a 52-week-low of $48.52. PDC Energy closed at $67.21 at the end of the last trading period.
For WalkMe Ltd (NASDAQ:WKME), Barclays downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, WalkMe had an EPS of $0.19, compared to year-ago quarter EPS of $0.16. The current stock performance of WalkMe shows a 52-week-high of $19.98 and a 52-week-low of $7.60. Moreover, at the end of the last trading period, the closing price was at $8.05.
According to Barclays, the prior rating for Pegasystems Inc (NASDAQ:PEGA) was changed from Equal-Weight to Underweight. For the second quarter, Pegasystems had an EPS of $0.38, compared to year-ago quarter EPS of $0.23. The current stock performance of Pegasystems shows a 52-week-high of $111.73 and a 52-week-low of $29.05. Moreover, at the end of the last trading period, the closing price was at $32.34.
Cowen & Co. downgraded the previous rating for ForgeRock Inc (NYSE:FORG) from Outperform to Market Perform. In the second quarter, ForgeRock showed an EPS of $0.17, compared to $0.40 from the year-ago quarter. The current stock performance of ForgeRock shows a 52-week-high of $27.61 and a 52-week-low of $11.94. Moreover, at the end of the last trading period, the closing price was at $22.54.
Barclays downgraded the previous rating for UiPath Inc (NYSE:PATH) from Overweight to Equal-Weight. UiPath earned $0.02 in the second quarter, compared to $0.01 in the year-ago quarter. The current stock performance of UiPath shows a 52-week-high of $44.13 and a 52-week-low of $11.10. Moreover, at the end of the last trading period, the closing price was at $12.13.
Cowen & Co. downgraded the previous rating for KnowBe4 Inc (NASDAQ:KNBE) from Outperform to Market Perform. KnowBe4 earned $0.07 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.00 and a 52-week-low of $13.78. KnowBe4 closed at $24.49 at the end of the last trading period.
RBC Capital downgraded the previous rating for NeuBase Therapeutics Inc (NASDAQ:NBSE) from Outperform to Sector Perform. In the third quarter, NeuBase Therapeutics showed an EPS of $0.26, compared to $0.29 from the year-ago quarter. The current stock performance of NeuBase Therapeutics shows a 52-week-high of $3.18 and a 52-week-low of $0.27. Moreover, at the end of the last trading period, the closing price was at $0.31.
According to UBS, the prior rating for RPM International Inc (NYSE:RPM) was changed from Buy to Neutral. In the first quarter, RPM International showed an EPS of $1.47, compared to $1.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $101.48 and a 52-week-low of $74.56. RPM International closed at $91.78 at the end of the last trading period.
According to Goldman Sachs, the prior rating for NGM Biopharmaceuticals Inc (NASDAQ:NGM) was changed from Buy to Neutral. For the second quarter, NGM Biopharmaceuticals had an EPS of $0.59, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $19.14 and a 52-week-low of $2.92. NGM Biopharmaceuticals closed at $3.41 at the end of the last trading period.
For ACM Research Inc (NASDAQ:ACMR), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. ACM Research earned $0.22 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $91.59 and a 52-week-low of $7.56. At the end of the last trading period, ACM Research closed at $8.13.
According to Raymond James, the prior rating for NGM Biopharmaceuticals Inc (NASDAQ:NGM) was changed from Strong Buy to Outperform. For the second quarter, NGM Biopharmaceuticals had an EPS of $0.59, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $19.14 and a 52-week-low of $2.92. At the end of the last trading period, NGM Biopharmaceuticals closed at $3.41.
RBC Capital downgraded the previous rating for Resolute Forest Products Inc (NYSE:RFP) from Outperform to Sector Perform. In the second quarter, Resolute Forest Prods showed an EPS of $2.00, compared to $3.74 from the year-ago quarter. The current stock performance of Resolute Forest Prods shows a 52-week-high of $21.07 and a 52-week-low of $11.00. Moreover, at the end of the last trading period, the closing price was at $20.86.
For Syneos Health Inc (NASDAQ:SYNH), JP Morgan downgraded the previous rating of Overweight to Neutral. For the second quarter, Syneos Health had an EPS of $1.25, compared to year-ago quarter EPS of $0.97. At the moment, the stock has a 52-week-high of $102.67 and a 52-week-low of $44.22. Syneos Health closed at $48.19 at the end of the last trading period.
According to BTIG, the prior rating for RingCentral Inc (NYSE:RNG) was changed from Buy to Neutral. In the second quarter, RingCentral showed an EPS of $0.45, compared to $0.32 from the year-ago quarter. The current stock performance of RingCentral shows a 52-week-high of $194.40 and a 52-week-low of $31.30. Moreover, at the end of the last trading period, the closing price was at $34.29.
See all analyst ratings downgrades.
Initiations
Craig-Hallum initiated coverage on Viant Technology Inc (NASDAQ:DSP) with a Buy rating. The price target for Viant Technology is set to $7.00. Viant Technology earned $0.08 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $10.23 and a 52-week-low of $3.85. At the end of the last trading period, Viant Technology closed at $4.15.
Lake Street initiated coverage on Domo Inc (NASDAQ:DOMO) with a Buy rating. The price target for Domo is set to $25.00. In the second quarter, Domo showed an EPS of $0.26, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $57.41 and a 52-week-low of $14.00. Domo closed at $15.78 at the end of the last trading period.
DA Davidson initiated coverage on PropTech Investment Corp II (NASDAQ:PTIC) with a Buy rating. The price target for PropTech Investment is set to $12.00.
With an Outperform rating, Keefe, Bruyette & Woods initiated coverage on Esquire Financial Holdings Inc (NASDAQ:ESQ). The price target seems to have been set at $53.00 for Esquire Financial Hldgs. In the second quarter, Esquire Financial Hldgs showed an EPS of $0.78, compared to $0.57 from the year-ago quarter. The current stock performance of Esquire Financial Hldgs shows a 52-week-high of $41.68 and a 52-week-low of $31.59. Moreover, at the end of the last trading period, the closing price was at $38.88.
Evercore ISI Group initiated coverage on Kimberly-Clark Corp (NYSE:KMB) with an In-Line rating. In the second quarter, Kimberly-Clark showed an EPS of $1.34, compared to $1.47 from the year-ago quarter. The current stock performance of Kimberly-Clark shows a 52-week-high of $145.79 and a 52-week-low of $108.74. Moreover, at the end of the last trading period, the closing price was at $114.18.
Evercore ISI Group initiated coverage on Clorox Co (NYSE:CLX) with an Underperform rating. For the fourth quarter, Clorox had an EPS of $0.93, compared to year-ago quarter EPS of $0.95. At the moment, the stock has a 52-week-high of $186.86 and a 52-week-low of $120.50. Clorox closed at $133.19 at the end of the last trading period.
With a Equal-Weight rating, Morgan Stanley initiated coverage on The Trade Desk Inc (NASDAQ:TTD). The price target seems to have been set at $60.00 for Trade Desk. For the second quarter, Trade Desk had an EPS of $0.20, compared to year-ago quarter EPS of $0.18. The stock has a 52-week-high of $93.26 and a 52-week-low of $39.00. At the end of the last trading period, Trade Desk closed at $54.61.
With a Buy rating, UBS initiated coverage on ProKidney Corp (NASDAQ:PROK). The price target seems to have been set at $18.00 for ProKidney. For the second quarter, ProKidney had an EPS of $0.12, compared to year-ago quarter EPS of $0.09. The current stock performance of ProKidney shows a 52-week-high of $11.98 and a 52-week-low of $6.19. Moreover, at the end of the last trading period, the closing price was at $9.97.
EF Hutton initiated coverage on Bone Biologics Corp (NASDAQ:BBLG) with a Buy rating. The price target for Bone Biologics is set to $2.25. In the second quarter, Bone Biologics showed an EPS of $0.05, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.78 and a 52-week-low of $0.50. Bone Biologics closed at $0.53 at the end of the last trading period.
Truist Securities initiated coverage on Keros Therapeutics Inc (NASDAQ:KROS) with a Buy rating. The price target for Keros Therapeutics is set to $100.00. In the second quarter, Keros Therapeutics showed an EPS of $1.13, compared to $0.67 from the year-ago quarter. At the moment, the stock has a 52-week-high of $68.29 and a 52-week-low of $24.38. Keros Therapeutics closed at $46.25 at the end of the last trading period.
JMP Securities initiated coverage on Benitec Biopharma Inc (NASDAQ:BNTC) with a Market Outperform rating. The price target for Benitec Biopharma is set to $4.00. In the fourth quarter, Benitec Biopharma showed an EPS of $0.62, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.05 and a 52-week-low of $0.20. Benitec Biopharma closed at $0.24 at the end of the last trading period.
With a Market Outperform rating, JMP Securities initiated coverage on Exelixis Inc (NASDAQ:EXEL). The price target seems to have been set at $26.00 for Exelixis. In the second quarter, Exelixis showed an EPS of $0.28, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.40 and a 52-week-low of $14.87. Exelixis closed at $16.33 at the end of the last trading period.
Wolfe Research initiated coverage on Simon Property Group Inc (NYSE:SPG) with a Peer Perform rating. Simon Property Group earned $2.91 in the second quarter, compared to $3.24 in the year-ago quarter. The current stock performance of Simon Property Group shows a 52-week-high of $165.83 and a 52-week-low of $86.02. Moreover, at the end of the last trading period, the closing price was at $99.15.
Barclays initiated coverage on Intuitive Surgical Inc (NASDAQ:ISRG) with an Overweight rating. The price target for Intuitive Surgical is set to $235.00. The current stock performance of Intuitive Surgical shows a 52-week-high of $362.00 and a 52-week-low of $180.07. Moreover, at the end of the last trading period, the closing price was at $190.12.
Barclays initiated coverage on Abbott Laboratories (NYSE:ABT) with an Overweight rating. The price target for Abbott Laboratories is set to $118.00. For the second quarter, Abbott Laboratories had an EPS of $1.43, compared to year-ago quarter EPS of $1.17. The current stock performance of Abbott Laboratories shows a 52-week-high of $139.83 and a 52-week-low of $96.67. Moreover, at the end of the last trading period, the closing price was at $103.52.
Barclays initiated coverage on Zimmer Biomet Holdings Inc (NYSE:ZBH) with an Underweight rating. The price target for Zimmer Biomet Holdings is set to $104.00. Zimmer Biomet Holdings earned $1.82 in the second quarter, compared to $1.90 in the year-ago quarter. The stock has a 52-week-high of $135.05 and a 52-week-low of $100.39. At the end of the last trading period, Zimmer Biomet Holdings closed at $110.51.
Barclays initiated coverage on Baxter International Inc (NYSE:BAX) with an Overweight rating. The price target for Baxter Intl is set to $64.00. In the second quarter, Baxter Intl showed an EPS of $0.87, compared to $0.80 from the year-ago quarter. The stock has a 52-week-high of $89.70 and a 52-week-low of $53.78. At the end of the last trading period, Baxter Intl closed at $55.25.
With an Overweight rating, Barclays initiated coverage on Tandem Diabetes Care Inc (NASDAQ:TNDM). The price target seems to have been set at $75.00 for Tandem Diabetes Care. In the second quarter, Tandem Diabetes Care showed an EPS of $0.24, compared to $0.06 from the year-ago quarter. The current stock performance of Tandem Diabetes Care shows a 52-week-high of $150.64 and a 52-week-low of $42.90. Moreover, at the end of the last trading period, the closing price was at $55.10.
Barclays initiated coverage on Boston Scientific Corp (NYSE:BSX) with an Overweight rating. The price target for Boston Scientific is set to $49.00. In the second quarter, Boston Scientific showed an EPS of $0.44, compared to $0.40 from the year-ago quarter. The current stock performance of Boston Scientific shows a 52-week-high of $47.49 and a 52-week-low of $34.98. Moreover, at the end of the last trading period, the closing price was at $40.86.
Barclays initiated coverage on Stryker Corp (NYSE:SYK) with an Overweight rating. The price target for Stryker is set to $239.00. In the second quarter, Stryker showed an EPS of $2.25, compared to $2.25 from the year-ago quarter. The stock has a 52-week-high of $280.43 and a 52-week-low of $188.84. At the end of the last trading period, Stryker closed at $215.63.
Barclays initiated coverage on NuVasive Inc (NASDAQ:NUVA) with an Overweight rating. The price target for NuVasive is set to $53.00. For the second quarter, NuVasive had an EPS of $0.47, compared to year-ago quarter EPS of $0.60. The current stock performance of NuVasive shows a 52-week-high of $60.47 and a 52-week-low of $39.57. Moreover, at the end of the last trading period, the closing price was at $42.05.
With a Equal-Weight rating, Barclays initiated coverage on DexCom Inc (NASDAQ:DXCM). The price target seems to have been set at $103.00 for DexCom. In the second quarter, DexCom showed an EPS of $0.17, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $539.06 and a 52-week-low of $67.11. DexCom closed at $99.73 at the end of the last trading period.
Barclays initiated coverage on Medtronic PLC (NYSE:MDT) with a Equal-Weight rating. The price target for Medtronic is set to $90.00. Medtronic earned $1.13 in the first quarter, compared to $1.41 in the year-ago quarter. The current stock performance of Medtronic shows a 52-week-high of $114.31 and a 52-week-low of $79.44. Moreover, at the end of the last trading period, the closing price was at $82.76.
Barclays initiated coverage on Edwards Lifesciences Corp (NYSE:EW) with an Overweight rating. The price target for Edwards Lifesciences is set to $96.00. For the second quarter, Edwards Lifesciences had an EPS of $0.63, compared to year-ago quarter EPS of $0.64. At the moment, the stock has a 52-week-high of $131.10 and a 52-week-low of $80.69. Edwards Lifesciences closed at $85.49 at the end of the last trading period.
With an Overweight rating, Barclays initiated coverage on Globus Medical Inc (NYSE:GMED). The price target seems to have been set at $69.00 for Globus Medical. For the second quarter, Globus Medical had an EPS of $0.56, compared to year-ago quarter EPS of $0.56. The stock has a 52-week-high of $81.78 and a 52-week-low of $52.60. At the end of the last trading period, Globus Medical closed at $63.95.
Barclays initiated coverage on Insulet Corp (NASDAQ:PODD) with a Equal-Weight rating. The price target for Insulet is set to $238.00. For the second quarter, Insulet had an EPS of $0.06, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $283.28 and a 52-week-low of $181.00. At the end of the last trading period, Insulet closed at $224.16.
With a Buy rating, Rosenblatt initiated coverage on Bentley Systems Inc (NASDAQ:BSY). The price target seems to have been set at $37.00 for Bentley Systems. In the second quarter, Bentley Systems showed an EPS of $0.22, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $48.91 and a 52-week-low of $26.32. Bentley Systems closed at $32.51 at the end of the last trading period.
